- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 28, 2025 | 18.64M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 17.98M sh |
| Capex | FY 2024 · Dec 31, 2023 | $95K |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | $25.48M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $10.48M |
| Total Liabilities restated | FY 2024 · Dec 31, 2023 | $28.8M |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $1.12B |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$0.25 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$0.25 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $1.66M |
| Net Income restated | FY 2024 · Dec 31, 2023 | −$4.49M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | −$1.78M |
| Revenue restated | FY 2024 · Dec 31, 2023 | $47.26M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | $223.2M |